ProfileOfResearchers

TITLE: Effects of sevelamer and calcium carbonate on bone mineralisation and turnover in chronic maintenance haemodialysis patients
AUTHORS: Anibal Ferreira; Joao Miguel Frazao ; Marie Claude Faugere; Regula Mueller; Hartmut Malluche;
PUBLISHED: 2006, SOURCE: 43rd ERA-EDTA Congress in NEPHROLOGY DIALYSIS TRANSPLANTATION, VOLUME: 21

INDEXED IN:

WOS

IN MY:

ResearcherID

TITLE: The Optima study: Earlier intervention of Cinacalcet HCl (Sensipar (R)/Mimpara (R)) enables greater achievement of KDOQI (TM) secondary hyperparathyroidism (SHPT) targets in dialysis patients.
AUTHORS: Frazao, JM ; Macario, F; Yaqoob, M; Bouman, K; Braun, J; von Albertini, B; Brink, HS; Maduell, F; Graf, H; Saha, H; Zani, V; Carter, D; Molemans, B; Messa, P;
PUBLISHED: 2006, SOURCE: Spring Clinical Meeting of the National-Kidney-Foundation in AMERICAN JOURNAL OF KIDNEY DISEASES, VOLUME: 47, ISSUE: 4

INDEXED IN:

WOS

TITLE: Vascular calcifications and bone turnover in hemodialysis patients
AUTHORS: Adragao, T; Ferreira, A; Frazao, JM ; Gil, C; Oliveira, C; Galvao, J; Sarmento, M; Ribeiro, S; Dickson, J; Carvalho, B; Rodrigues, I; Baldaia, J; Pereira, O; Faugere, MC; Malluche, HH;
PUBLISHED: 2006, SOURCE: 43rd ERA-EDTA Congress in NEPHROLOGY DIALYSIS TRANSPLANTATION, VOLUME: 21

INDEXED IN:

WOS

IN MY:

ResearcherID

TITLE: Cinacalcet (MIMPARA (R)/SENSIPAR (R)) maintains achievement of NKF-K/DOQI treatment targets for secondary hyperparathyroidism (HPT) in patients on dialysis
AUTHORS: Frazao, JM ; Holzer, H; Stummvoll, HK; Bahner, U; Wilkie, M; Zani, V; Hutton, H; Motellon, JL; Braun, J;
PUBLISHED: 2005, SOURCE: 42nd Annual Meeting of the European-Renal-Association/European-Dialysis-and-Transplant-Association (ERA-EDTA) in NEPHROLOGY DIALYSIS TRANSPLANTATION, VOLUME: 20

INDEXED IN:

WOS

TITLE: Calcimimetic agents: Review and perspectives
AUTHORS: Urena, P; Frazao, JM ;
PUBLISHED: 2003, SOURCE: Kidney International, Supplement, VOLUME: 63, ISSUE: 85

INDEXED IN:

Scopus

IN MY:

ORCID |

CIÊNCIAVITAE

TITLE: Calcimimetic agents: Review and perspectives Full Text
AUTHORS: Pablo Ureña; João M Frazão ;
PUBLISHED: 2003, SOURCE: Kidney International, VOLUME: 63

INDEXED IN:

CrossRef: 36

IN MY:

ORCID |

CIÊNCIAVITAE

TITLE: Calcimimetic agents: Review and perspectives Full Text
AUTHORS: Urena, P; Frazao, JM ;
PUBLISHED: 2003, SOURCE: 4th Symposium on Advances in Renal Osteodystrophy in KIDNEY INTERNATIONAL, VOLUME: 63

INDEXED IN:

WOS

IN MY:

ResearcherID

TITLE: Cinacalcet HCI is an effective primary therapy for the management of secondary hyperparathyroidism (HPT).
AUTHORS: Goodman, WG; Fadda, GZ; Finkelstein, FO; Mittman, N; Lien, YH; Leblanc, M; Locatelli, F; Frazao, JM ; Olgaard, K; Olson, KA; McCary, LC; Turner, SA; Quarles, LD;
PUBLISHED: 2003, SOURCE: 36th Annual Meeting of the American-Society-of-Nephrology in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, VOLUME: 14

INDEXED IN:

WOS

IN MY:

ResearcherID

TITLE: The calcimimetic agents: Perspectives for treatment Full Text
AUTHORS: Frazao, JM ; Martins, P; Coburn, JW;
PUBLISHED: 2002, SOURCE: 1st International Conference on New Insights in End-Stage Renal Disease in KIDNEY INTERNATIONAL, VOLUME: 61, ISSUE: 80

INDEXED IN:

Scopus

WOS

IN MY:

ORCID |

ResearcherID |

CIÊNCIAVITAE

TITLE: Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1 alpha-hydroxyvitamin D-2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison
AUTHORS: Maung, HM; Elangovan, L; Frazao, JM ; Bower, JD; Kelley, BJ; Acchiardo, SR; Rodriguez, HJ; Norris, KC; Sigala, JF; Rutkowski, M; Robertson, JA; Goodman, WG; Levine, BS; Chesney, RW; Mazess, RB; Kyllo, DM; Douglass, LL; Bishop, CW; Coburn, JW;
PUBLISHED: 2001, SOURCE: AMERICAN JOURNAL OF KIDNEY DISEASES, VOLUME: 37, ISSUE: 3

INDEXED IN:

Scopus

WOS

CrossRef: 71

IN MY:

ORCID |

ResearcherID |

CIÊNCIAVITAE